MedPath

Patient Perception of Visual Distortions

Completed
Conditions
Cataract
Astigmatism
Interventions
Other: Administration of patient self-assessment
Registration Number
NCT02203747
Lead Sponsor
Abbott Medical Optics
Brief Summary

The purpose of this study is to evaluate visual distortions reported by pseudophakic patients.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
79
Inclusion Criteria
  • Corneal astigmatism of at least 0.75 diopters
  • Bilaterally-implanted with monofocal toric intraocular lenses in both eyes or with monofocal non-toric intraocular lenses in both eyes
  • At least one month postoperative from second-eye surgery
  • Ability to understand, read and write English to give consent and complete study questionnaire
  • Availability, willingness, and sufficient cognitive awareness to comply with examination procedures and study visits
  • Sign informed consent and Health Insurance Portability and Accountability Act (HIPAA) authorization
  • Other protocol-defined inclusion criteria may apply
Exclusion Criteria
  • Any ocular pathology of clinical significance, as determined by the investigator, other than regular corneal astigmatism, that may affect visual outcomes or influence subjective ocular visual symptoms
  • Patient is pregnant or is lactating
  • Participation in any other clinical trial during the last 30 days prior to study enrollment or concurrent participation in any other ongoing clinical trial
  • Other protocol-defined exclusion criteria may apply

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Pseudophakic implanted with non-toric IOLAdministration of patient self-assessmentSubjects bilaterally implanted with non-toric IOL
Pseudophakic implanted with toric IOLAdministration of patient self-assessmentSubjects bilaterally implanted with toric IOL
Primary Outcome Measures
NameTimeMethod
Visual Distortion Symptoms1 week

Subjective rating of visual distortion symptoms under overall conditions at baseline. Rating scale consisted of the following categories: "did not experience" (rating = 0), "mild" (rating = 1), "moderate" (rating = 2), or "severe" (rating = 3), therefore, the lower values represent the best outcome. The minimum score was 0 and the maximum score was 3.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Contact AMO for Trial Locations

🇺🇸

Santa Ana, California, United States

© Copyright 2025. All Rights Reserved by MedPath